C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL

Temesgen, Zelalem, Burger, Charles, Baker, Jason, Polk, Christopher, Libertin, Claudia, Kelley, Colleen, Marconi, Vincent, Orenstein, Robert, Catterson, Victoria, Aronstein, William, Durrant, Cameron, Chappell, Dale, Chappell, Gabrielle, Ahmed, Omar, Badley, Andrew

Temesgen, Zelalem, Burger, Charles, Baker, Jason, Polk, Christopher, Libertin, Claudia, Kelley, Colleen, Marconi, Vincent, Orenstein, Robert, Catterson, Victoria, Aronstein, William, Durrant, Cameron, Chappell, Dale, Chappell, Gabrielle, Ahmed, Omar, Badley, Andrew.

CHEST ; 160(4):A2522-A2524, 2021.

Article in English | Academic Search Complete | ID: covidwho-1460946

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Type of study: Randomized controlled trials Language: English Journal: CHEST Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google